Grant Details
| Status | Active |
|---|---|
| Effective start/end date | 01/1/13 → … |
Funding
- Conquer Cancer Foundation: $50,000.00
HER2 gene polymorphism (Ile655Val): Correlation with prognosis and cardiac toxicity in breast cancer patients treated with trastuzumab.
- Peddi, Parvin (PI)
Project: Research